DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Iveson T. et al.
Final DFS results of the SCOT study: An international phase III randomised (1:1) non-inferiority trial comparing 3 versus 6 months of oxaliplatin based adjuvant chemotherapy for colorectal cancer.
J Clin Oncol 2017
35. (suppl; abstr 3502)
Access:
We do not assume any responsibility for the contents of the web pages of other providers.